Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US. (4th March 2021)

• Record Type: Journal Article
• Authors: Deb, Arijita; Mohanty, Salini; Ou, Wanmei; Rajagopalan, Srinivasan; Johnson, Kelly D
• Is Part Of: Expert review of vaccines. Volume 20:Number 3(2021)
• Page Start: 331
• Page End: 345
• Publication Date: 2021-03-04
• Subjects: Vaccination coverage -- pneumococcal vaccines -- Streptococcus pneumoniae -- pneumococcal infections; Vaccines -- Periodicals; Vaccination -- Periodicals; 615.37205
• DOI: 10.1080/14760584.2021.1898377
• Languages: English
• ISSNs: 1476-0584

Abstract

ABSTRACT: Background : Adults with immuno-compromising conditions, CSF leaks, or cochlear implants are at increased risk for pneumococcal disease (high-risk patients), yet pneumococcal vaccination rates in the US for this group are low. Methods : A retrospective cohort analysis was conducted from 2010 to 2018 using the Truven Health MarketScan database to estimate pneumococcal vaccination coverage among adults aged 19 to 64 years newly diagnosed with high-risk conditions, and to assess factors associated with receiving the recommended pneumococcal vaccines. Results : The study sample included 2, 497, 799 adults aged 19 to 64 years old with newly diagnosed high-risk conditions. Most of the study cohort had seven or more annual physician office (52%) and pharmacy (56%) visits. The proportion of high-risk adults who received at least one pneumococcal vaccination increased from 5.4% after 1 year of follow-up to 14.2% after 6 years of follow-up. Compared to those who received no pneumococcal vaccination, high-risk adults who received any pneumococcal vaccination were more likely to be older, female, enrolled in an HMO, had more healthcare encounters, and were treated by a primary care provider. Conclusion : Despite numerous healthcare encounters annually, very few high-risk adults received pneumococcal vaccines, highlighting the need for implementing targeted interventions to increase vaccine uptake in this vulnerable population.